• By ICR Secretariat
  • Posted Monday, July 29, 2019

As new prime minister takes the helm, U.K.-based GSK still balks at 'no deal'

https://www.fiercebiotech.com/biotech/as-a-new-prime-minister-takes-to-helm-u-k-based-gsk-still-baulks-as-no-deal

It wasn’t the best timing for GlaxoSmithKline’s second-quarter financial call: While CEO Emma Walmsley went through the numbers, Britain’s Prime Minister Theresa May was giving her last speech as prime minister in Parliament.